PDCD1 and lymphoma: However, the ligant PD-L1 is often overexpressed in different tumor including lymphoma, melanoma, non-small-cell lung cancer and other types, making the PD-1/PD-L1 signaling pathway crucial in dampening the immune surveillance of the tumor29.